EP Patent

EP3872076A1 — Opioid receptor ligands and methods of using and making same

Assigned to Trevena Inc · Expires 2021-09-01 · 5y expired

What this patent protects

This application describes compounds that can act as opioid receptor ligands, which compounds can be used in the treatment of, for example, pain and pain related disorders.

USPTO Abstract

This application describes compounds that can act as opioid receptor ligands, which compounds can be used in the treatment of, for example, pain and pain related disorders.

Drugs covered by this patent

Patent Metadata

Patent number
EP3872076A1
Jurisdiction
EP
Classification
—
Expires
2021-09-01
Drug substance claim
No
Drug product claim
No
Assignee
Trevena Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.